The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing

Journal of Experimental Medicine

Volumn 193, Issue 2, 2001, Pages 195-205

  Brickner, Anthony G ^a   Warren, Edus H ^b,c   Caldwell, Jennifer A ^d   Akatsuka, Yoshiki ^b,c   Golovina, Tatiana N ^e   Zarling, Angela L ^a   Shabanowitz, Jeffrey ^d   Eisenlohr, Laurence C ^e   Hunt, Donald F ^a,d   Engelhard, Victor H ^a,f   Riddell, Stanley R ^b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b USA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Antigen processing; Fourier transform mass spectrometry; Graft versus host disease; Minor histocompatibility antigens; Transplantation

Indexed keywords

MINOR HISTOCOMPATIBILITY ANTIGEN;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CHROMOSOME 9; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE AMPLIFICATION; GENE SEQUENCE; GENE TRANSLOCATION; GENOTYPE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ALLELES; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; BASE SEQUENCE; CLONE CELLS; DNA PRIMERS; EPITOPES; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MINOR HISTOCOMPATIBILITY ANTIGENS; MOLECULAR SEQUENCE DATA; PEDIGREE; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0035862328     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.2.195     Document Type: Article

References (54)

1. Graft-versus-leukemia reactions after bone marrow transplantation
2. Minor histocompatibility antigens and marrow transplantation
3. Alloimmunity to human H-Y
4. Human minor histocompatibility antigens
5. A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease
6. Minor histocompatibility antigens in man and their role in transplantation
7. Human minor histocompatibility antigens
8. Taming the sinister side of BMT: Dr. Jekyll and Mr. Hyde
9. The immune system: Effector and target of graft-versus-host disease
10. Immunogenetic factors relevant to acute GVHD
11. Graft-versus-host disease
12. Identification of classical minor histocompatibility antigen as cell-derived peptide
13. Minor histocompatibility antigens
14. Catalog of mutant genes and polymorphic loci. 3rd ed
15. How much benefit can be expected from matching for minor antigens in allogeneic marrow transplantation?
16. Human minor histocompatibility antigens: New concepts for marrow transplantation and adoptive immunotherapy
17. Tissue distribution of human minor histocompatibility antigens: Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte defined non-MHC antigens
18. Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact
19. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells
20. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution
21. The human HY gene encodes a novel HLA-B8-restricted H-Y antigen
22. Identification of a graft versus host disease-associated human minor histocompatibility antigen
23. Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein
24. The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism
25. The HLA-A*0201-restricted HY antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition
26. The HLA-A*0101 restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique
27. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia
28. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells
29. Monoclonal antibodies for analysis of the HLA system
30. Quantitative analysis of individual neurons by open tubular liquid chromatography with voltammetric detection
31. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines
32. Sequencing the primordial soup
33. Sub-femtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI Fourier transform ion cyclotron resonance mass spectrometry
34. Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2.1 with high affinity and in different conformations
35. Determination of intronic sequences adjacent to an exon using PCR and genomic library constructed by TA cloning
36. Improvement in HLA-DQB typing by PCR-RFLP: Introduction of a constant restriction site in one of the primers for digestion control
37. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide
38. Murine transporter associated with antigen presentation (TAP) preferences influence class 1-restricted T cell responses
39. Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences
40. 131I labelled human growth hormone of high specific radioactivity
41. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1
42. Maternally transmitted histocompatibility antigen of mice: A hydrophobic peptide of a mitochondrially encoded protein
43. Positional cloning and molecular characterization of an immunodominant cytotoxic determinant of the mouse H3 minor histocompatibility complex
44. Minors held by majors. The H13 minor histocompatibility locus defined as a peptide/MHC class I complex
45. Identification of the rat maternally transmitted minor histocompatibility antigen
46. b epitope is encoded by a novel mouse Y chromosome gene
47. Trimming of antigenic peptides in an early secretory compartment
48. The protease inhibitor. N-acetyl- L-leucyl-L-leucyl-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum
49. Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolase 1
50. An algorithm for the prediction of proteasomal cleavages
51. Selectivity of MHC-encoded peptide transporters from human, mouse and rat
52. Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries
53. The peptide-binding motif for the human transporter associated with antigen processing
54. Protein sequencing by tandem mass spectrometry